The Cigna Group posted strong Q3 2024 results, yet CI stock is down nearly 20% from its 52-week high. See why this may ...

The Cigna Group reported $739 million in profit for the third quarter, a figure that accounts for a $1 billion after-tax ...

As Cigna and Humana pick back up on the potential for a megamerger, executives will be keeping a close eye on the outcomes of ...

Despite reports this fall that the two payers had reopened merger talks, Cigna plans to use excess cash to buy back its ...

Cigna and Humana are reportedly in talks about a possible merger, nearly a year after a similar deal fell through.

However, she notes the complementary nature of the two companies' strengths: Cigna is a powerhouse in the pharmacy benefit management (PBM) space, while Humana focuses more on government insurance ...

since Humana's PBM largely serves its internal clientele, and we do not think Cigna would want to part with the top-tier PBM that it operates following the 2018 acquisition of Express Scripts.

Cigna is pursuing several growth channels. Naturally, Cigna's bulked-up service offerings should allow it to cross-sell traditional PBM and specialty pharmacy services into its managed-care client ...

The company's Evernorth business, which includes its PBM services, has shown particular strength, contributing significantly to overall performance. Looking ahead to 2025, Cigna's management has ...

In late September, the Federal Trade Commission (FTC) said that it had taken legal action against the three largest PBMs (CVS Health’s Caremark, Cigna ... about the PBM industry in a report ...

Market Leadership in Pharmacy Benefit Management: The Cigna Group's merger with Express Scripts in 2018 significantly bolstered its pharmacy benefit management (PBM) and specialty pharmacy services.

In the third quarter of 2024, Cigna reported solid financial results, reaffirming its full-year guidance for 2024 with an EPS of at least $28.40. The company's Evernorth business, which includes its ...